SPRINT BIOSCIENCE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.334 SEK | +9.88% |
|
-1.91% | -23.11% |
| 05-08 | Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-14 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Sprint Bioscience AB
c1bb9476e4127ca3b06af1b99.eHYV-oUNs7aqCqLDFz8Mzp5YdZ71tilCkaB33VmAFjU.EwxNzsda1djiZOe5XG5IisgaJfaN3EYTy84hrTTtIFsfPCyS3GL47Ntd0Q~8410d89a07cf78225dbfc16e982d5428
Upcoming events on Sprint Bioscience AB
Past events on Sprint Bioscience AB
| 07/05/2024 | Q1 2024 Earnings Release (Projected) |
| 13/02/2024 | Q4 2023 Earnings Release |
| 23/01/2024 | Redeye Fight Cancer Webinar. |
| 25/10/2023 | BioStock Life Science Fall Summit |
| 24/10/2023 | Q3 2023 Earnings Release |
| 23/08/2023 | Q2 2023 Earnings Release |
| 01/06/2023 05:00 | Redeye Growth Day |
| 09/05/2023 | Annual General Meeting |
| 09/05/2023 | Q1 2023 Earnings Release |
| 08/05/2023 | STING & TLR Targeting Therapies Summit |
| 14/02/2023 | FY 2022 Earnings Release |
| 19/01/2023 05:00 | Redeye Fight Cancer Seminar |
| 29/11/2022 | BioStock Life Science Fall Summit |
| 26/11/2022 | Redeye Life Science Day_Interview |
| 25/10/2022 | Q3 2022 Earnings Release |
| 11/05/2022 06:30 | Q1 2022 Earnings Release |
| 10/05/2022 | Annual General Meeting |
| 15/02/2022 | FY 2021 Earnings Release |
| 10/11/2021 | Redeye Life Science Day |
| 26/10/2021 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 33,5 | 16,9 15,0 12.57% | 35,1 35,0 0.33% | 0,08 32,0 -99.74% | 50,5 58,0 -12.96% | 96,0 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 | -37,2 -30,2 -23.02% | -25,0 -23,0 -8.86% | -60,1 -29,0 -107.32% | -0,40 6,00 -106.63% | 21,0 |
|
EBIT Million SEK | Released Forecast Spread | 0,00 | -37,8 -30,9 -22.49% | -25,6 -23,0 -11.43% | -60,7 -29,0 -109.45% | -0,85 6,00 -114.08% | 20,0 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 | -42,8 -30,9 -38.49% | -25,1 -23,0 -9.06% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million SEK | Released Forecast Spread | 0,00 | -42,8 -30,9 -38.49% | -25,1 -23,0 -9.06% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EPS SEK | Released Forecast Spread | -1,92 | -2,55 -1,84 -38.59% | -0,85 -0,80 -6.25% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
| Announcement Date | 19/02/20 | 17/02/21 | 16/02/22 | 15/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 |
|---|---|---|---|
|
EBITDA Million SEK | Released Forecast Spread | -5,05 1,60 -415.75% | |
|
EBIT Million SEK | Released Forecast Spread | -5,14 1,40 -467.29% | |
|
Net income Million SEK | Released Forecast Spread | 28,6 | |
|
EPS SEK | Released Forecast Spread | 0,41 | |
| Announcement Date | 25/10/23 | 14/02/24 |
More events
Past sector events for Sprint Bioscience AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SPRINT Stock
- Calendar Sprint Bioscience AB
